Levetiracetam as an Adjunctive Analgesic in Neoplastic Plexopathies

References

• Twycross R G, Fairfield S. Pain in far-advanced cancer. Pain 1982; 14: 303–310
   PubMed Web of Science ®Google Scholar
• Cleeland C S, Gonin R, Hatfield A K, et al. Pain and its treatment in out-patients with metastatic cancer. N Eng J Med 1994; 330: 592–596
   PubMed Web of Science ®Google Scholar
• Herndon C, Kalauokalani D, Cunningham A, Jackson K, Dunteman E. Anticipating and treating opioid associated adverse effects. Expert Opinion on Drug Safety 2003; 2: 305–319
   PubMedGoogle Scholar
• Beydoun A, Backonja M M. Mechanistic stratification of antineuralgic analgesics. J Pain Symptom Manage 2003; 25: S18–S30
   PubMedGoogle Scholar
• International Association for the Study of Pain: IASP pain terminology. Classification of Pain. Seattle, IASP Task Force on Taxonomy, 2nd ed, H Mersky, N Bogduk, 1994; 209–214
   Google Scholar
• Patt R B, Burton A W. Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management. Evaluation and Treatment of Chronic Pain, 3rd ed., G. Aronoff. Lipincott Williams and Wilkins, Baltimore 1998; 337–376
   Google Scholar
• Kori S H, Foley K M, Posner J B. Brachial plexus lesions in patients with cancer: 100 cases. Neurology 1981; 31: 45–50
   PubMed Web of Science ®Google Scholar
• Scott J F. Carcinoma invading nerve. Textbook of Pain. 2nd ed., P D Wall, R Melzack. Churchill Livingston, Edinburgh 1989; 598
   Google Scholar
• Jaekle K A, Young D F, Foley K M. The natural history of lumbosacral plexopathy in cancer. Neurology 1985; 35: 8–15
   Google Scholar
• Farrar J T, Portenoy R K. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology (Huntingt) 2001; 15: 1435–1442, 1445; discussion 1445, 1450–1453.
   Google Scholar
• Backonja M M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002; 59: S14–S17
   PubMed Web of Science ®Google Scholar
• Serpell M G. Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain 2002; 99: 557–566
   PubMed Web of Science ®Google Scholar
• Hardy J R, Rees E A, Gwilliam B, et al. A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manage 2001; 21: 204–209
   PubMed Web of Science ®Google Scholar
• Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998; 284: 474–479
   PubMed Web of Science ®Google Scholar
• Hanon E, Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 2001; 10: 287–293
   PubMed Web of Science ®Google Scholar
• Keppra^® prescribing information. UCB Pharma, Inc., Smyrna, GA
   Google Scholar
• Lukyanetz E A, Shkryl V M, Kostyuk P G. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 2002; 43: 9–18
   PubMed Web of Science ®Google Scholar
• Rigo J M, Hans G, Nguyen L, et al. The antiepileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 2002; 136: 656–672
   Google Scholar
• Patterson S M, Stewart S. Levetiracetam is effective in the treatment of chronic pain: A prospective open-label case series. Annual Meeting of the American Pain Society. March 20, 2003, Poster #949
   Google Scholar
• Pritchard D D, Kearney B P. Levetiracetam (Keppra): A community pain clinic experience with large numbers of patients with different types of pain. Annual Meeting of the American Pain Society. March 20, 2003, Poster #954
   Google Scholar
• Ren J, Manville N, Rowbotham M. Effect of levetiracetam on fibromyalgia pain and tenderness: Comparison with PHN. Annual Meeting of the American Pain Society. March 20, 2003, Poster #883
   Google Scholar
• Lindholm D. Levetiracetam levels correlating with successful treatment of epilepsy, headaches, cognitive effects, and adverse reactions in pediatric age group. Epilepsia 2002; 43: 60, Abstract 1.165
   Google Scholar
• Privitera M. Efficacy of levetiracetam: a review of three pivotal clinical trials. Epilepsia 2001; 42: 31–35
   PubMed Web of Science ®Google Scholar
• French J. Use of levetiracetam in special populations. Epilepsia 2001; 42: 40–43
   PubMed Web of Science ®Google Scholar
• Patsalos P N. Pharmacokinetic profile of levetiracetam: Toward ideal characteristics. Pharmacol Ther 2000; 85: 77–85
   PubMed Web of Science ®Google Scholar
• Adamec R E. Evidence of lasting potentiation of amygdala efferents in the right hemisphere underlies pharmacological stressor (FG-7142) induced lasting increases in anxiety-like behavior: role of GABA tone in initiation of brain and behavioral changes. J Psychopharm 2000; 14: 323–339
   Google Scholar
• Klees T M, Brodtkorb E, Nakken K O, Lossius R, Johannessen S I. Clinical experience with the new antiepileptic drug levetiracetam. Acta Neurol Scand 2003; 107: 428
   Google Scholar
• Patsalos P N. The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol 2003; 25: 123–129
   PubMed Web of Science ®Google Scholar
• Cramer J A, Van Hammee G. Maintenance Of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav 2003; 4: 118–123
   PubMedGoogle Scholar
• Jasmin L, Rabkin S D, Granato A, Boudah A, Ohara P T. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003; 424(6946)316–320
   PubMed Web of Science ®Google Scholar
• Simpson R K, Jr, Huang W. Glycine receptor reduction within segmental gray matter in the rat model in neuropathic pain. Neurol Res 1998; 20(2)161–168
   PubMed Web of Science ®Google Scholar
• Cizkova D, Marsala J, Lukacova N, Marsala M, Jercova S, Orendacova J, Yahsh T L. Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 2002; 147(4)456–463
   PubMed Web of Science ®Google Scholar
• Ardid D, Lamberty Y, Alloui A, Coudore-Caviale M A, Klitgaard H, Eschalier A. Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats. Eur J Pharmacol 2003; 473(1)27–33
   PubMed Web of Science ®Google Scholar
• Gentry J R, Hill C, Malcolm R. New anticonvulsants:a review of applications for the management of substance abuse disorders. Annals of Clinical Psychiatry 2002; 14(4)233–245
   PubMedGoogle Scholar
• Lamberty Y, Falter U, Gower A J, Klitgaard H. Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in the rat. Eur J Pharmacol 2003; 469(1–3)97–102
   PubMedGoogle Scholar